European Commission
Horizon-Miss-2026-02-Cancer-02
17:00 Brussels time
Last verified:
Horizon-MISS-2026-02 is a Horizon Europe Research and Innovation Action (RIA) supporting the European Cancer Mission, with a budget around €15 million for a single award. The call requires a multinational consortium of at least three entities from three different EU member states. This one-off call funds ambitious, cross-border cancer research projects aligned with the Cancer Mission's strategic goals.
Details
| Funder | European Commission |
| Budget | Around €15M |
| Deadline | 15 September 2026 |
| Consortium | Required — minimum 3 entities from 3 EU member states |
| Application | Single-stage |
| Frequency | One-off |
Eligibility & scope
Horizon Europe RIA under the Cancer Mission (Supporting the implementation of the Cancer Mission call HORIZON-MISS-2026-02). Single grant expected. Full topic description available in the call portal.
Who Should Apply
- •Research institutions, universities, or clinical centres in EU member states
- •Consortium leads capable of coordinating at least 3 organisations across 3 countries
- •Teams with demonstrated expertise in cancer research aligned with the Cancer Mission priorities
- •Organisations with prior Horizon Europe programme experience or strong track records in large collaborative grants
Key Dates
- •Deadline: 15 September 2026, 17:00 Brussels time
- •Single-stage evaluation
- •One-off call (not recurring)
Tips for Applicants
- ✓Consortium composition is gating: ensure all partners are confirmed and signed off before submission; late additions or weak justification for geographic spread will weaken the proposal.
- ✓The Cancer Mission framework is specific; align your project narrative and objectives explicitly to the published Cancer Mission goals and workstreams to avoid misalignment penalties.
- ✓RIA calls favour ambitious, high-risk research with clear innovation potential; include risk mitigation and feasibility pathways, especially for novel approaches.
Frequently Asked Questions
How much funding does Horizon-MISS-2026-02 offer?
Around €15 million for a single grant.
Who can apply to Horizon-MISS-2026-02?
Consortia of at least three entities from three different EU member states, including research institutions, universities, and clinical centres.
What is the deadline for Horizon-MISS-2026-02?
15 September 2026 at 17:00 Brussels time.
Is Horizon-MISS-2026-02 a recurring call?
No, this is a one-off call under the Cancer Mission.
Related on Grantsby
- European Commission writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from European Commission
Marie Sklodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2026
Deadline: 9 Sept 2026Marie Skłodowska-Curie Actions Postdoctoral Fellowships (MSCA-PF) 2026
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships (HORIZON-TMA-MSCA-PF-EF)
Deadline: 9 Sept 2026HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships (HORIZON-TMA-MSCA-PF-GF)
Deadline: 9 Sept 2026Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Deadline: 15 Sept 2026€7M–€8M per grant
Browse Related
Could Horizon-Miss-2026-02-Cancer-02 be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →